Literature DB >> 27760701

Course of illness in a sample of patients diagnosed with a schizotypal disorder and treated in a specialized early intervention setting. Findings from the 3.5year follow-up of the OPUS II study.

Nikolai Albert1, Louise Birkedal Glenthøj2, Marianne Melau3, Heidi Jensen3, Carsten Hjorthøj3, Merete Nordentoft2.   

Abstract

BACKGROUND: Previous studies report that 20% to 30% of those initially diagnosed with schizotypal disorder go on to develop a psychotic disorder (predominantly schizophrenia). Schizotypal disorder share some traits of those used to identify patients at ultra-high risk for psychosis.
METHOD: As part of a randomized clinical trial testing the effect of prolonged specialized early intervention, we recruited 83 participants diagnosed with a schizotypal disorder. Participants were recruited 18 months into their two-year treatment program, and follow-up interviews were conducted three and a half year later. They were randomized to either discontinuation after the standard two year treatment or continuation of the specialized treatment for totally five year. The study investigated whether prolonged treatment could affect the rate of transition to psychosis and other clinical outcomes, and what would predict transition to psychosis.
RESULTS: Of those 59 who attended the follow-up interview 19 (32%) developed a psychotic disorder at follow-up. There were no differences between the two treatment groups on transition rates or clinical outcomes. We found that lower level of functioning at baseline predicted transition to psychosis. DISCUSSION: Comparable to previous ultra-high risk studies, we found that level of functioning was the strongest predictor of transition to psychosis. Prior studies have found effect of specialized early intervention on transition rates, but we were not able to reproduce this finding. This may be attributable to the intervention in our study occurring at a later stage in the illness than prior studies.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Prolonged specialized early intervention; Schizotypal disorder; Specialized early intervention; Transition to psychosis

Mesh:

Year:  2016        PMID: 27760701     DOI: 10.1016/j.schres.2016.10.013

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  7 in total

Review 1.  Attrition rates in trials for adolescents and young adults at clinical high-risk for psychosis: A systematic review and meta-analysis.

Authors:  Megan S Farris; Daniel J Devoe; Jean Addington
Journal:  Early Interv Psychiatry       Date:  2019-08-18       Impact factor: 2.732

2.  Attenuated psychotic symptom interventions in youth at risk of psychosis: A systematic review and meta-analysis.

Authors:  Daniel J Devoe; Megan S Farris; Parker Townes; Jean Addington
Journal:  Early Interv Psychiatry       Date:  2018-05-11       Impact factor: 2.732

3.  Association of Substance Use Disorders With Conversion From Schizotypal Disorder to Schizophrenia.

Authors:  Carsten Hjorthøj; Nikolai Albert; Merete Nordentoft
Journal:  JAMA Psychiatry       Date:  2018-07-01       Impact factor: 21.596

4.  Antipsychotics are related to psychometric conversion to psychosis in ultra-high-risk youth.

Authors:  Antonio Preti; Andrea Raballo; Anna Meneghelli; Angelo Cocchi; Maria Meliante; Simona Barbera; Lara Malvini; Emiliano Monzani; Mauro Percudani
Journal:  Early Interv Psychiatry       Date:  2021-05-05       Impact factor: 2.721

5.  Specialised early intervention teams for recent-onset psychosis.

Authors:  Stephen Puntis; Amedeo Minichino; Franco De Crescenzo; Andrea Cipriani; Belinda Lennox; Rachael Harrison
Journal:  Cochrane Database Syst Rev       Date:  2020-11-02

6.  Specialised early intervention teams (extended time) for recent-onset psychosis.

Authors:  Stephen Puntis; Amedeo Minichino; Franco De Crescenzo; Andrea Cipriani; Belinda Lennox; Rachael Harrison
Journal:  Cochrane Database Syst Rev       Date:  2020-11-02

7.  Exploring schizophrenia spectrum psychopathology in borderline personality disorder.

Authors:  Maja Zandersen; Josef Parnas
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-07-09       Impact factor: 5.270

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.